Host factors contributing to susceptibility to COVID-19 disease

NIH Pandemic-Era Grants

Pandemic Era Grants

2021

↗ Live URL (may be dead)

Document text

Principal Investigator: Helen Chun-Hui Su
Organization: NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Fiscal Year: 2021
Award: $1,632,832
Funding agency: National Institute of Allergy and Infectious Diseases

These studies have been organized as part of a broader effort among multiple principal investigators in the Intramural Research Programs of NIAID, NIDCR, NCI, and NIAMS, as well as a research collaborative agreement with investigators at the American Genome Center/Uniformed Services University of the Health Sciences. We have assembled an international collaboration to study patients enrolled at centers in Italy, which was later expanded to include centers in East Asia, the Middle East, and the Americas. An IRB-approved COVID protocol involving send-in samples was written to facilitate studies at other centers lacking their own COVID protocols. We have partnered with the COVID-Human Genetic Effort, and multiple papers have come out of this international collaboration.

Terms: <0-11 years old><2019 novel corona virus><2019 novel coronavirus><2019-nCoV><Acute><Affect><Agreement><American><Americas><Biochemical><COVID><COVID-19><COVID-19 infection><COVID-19 virus><COVID19><COVID19 infection><COVID19 virus><CV-19><CV19><Child><Child Youth><Children (0-21)><CoV disease><CoV-2><CoV2><Collaborations><Convalescence><Disease><Disorder><East Asia><Eastern Asia><Enrollment><Family member><Far East><Gene variant><Genetic Determinism><Genome><Health Sciences><History><Host Factor><Host Factor Protein><Human><Human Genetics><IRB><IRBs><Immune><Immune response><Immunes><Immunological response><In Vitro><Individual><Institutional Review Boards><Integration Host Factors><International><Intramural Program><Intramural Research Program><Investigators><Italy><Knowledge><Life><Middle East><Modern Man><Molecular><NIAID><NIAMS><NIDCR><NIDR><National Institute of Allergy and Infectious Disease><National Institute of Arthritis and Musculoskeletal and Skin Diseases><National Institute of Dental Research><National Institute of Dental and Craniofacial Research><Outcome><P01 Mechanism><P01 Program><Paper><Pathogenesis><Pathway interactions><Patients><Population Genetics><Predisposition><Predisposition gene><Principal Investigator><Program Project Grant><Program Research Project Grants><Protocol><Protocols documentation><Recording of previous events><Research><Research Personnel><Research Program Projects><Researchers><SARS corona virus 2><SARS-CoV-2><SARS-CoV-2 infection><SARS-CoV2><SARS-CoV2 infection><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Sampling><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome coronavirus 2 infection><Severe acute respiratory syndrome related corona virus 2><Susceptibility><Susceptibility Gene><Therapeutic Intervention><University Health Services><Validation><Variant><Variation><Wuhan coronavirus><adaptive immune response><adult youth><allele variant><allelic variant><co-morbid><co-morbidity><comorbidity><consanguineous family><consanguineous kindreds><consanguineous pedigree><corona virus disease><corona virus disease 2019><coronavirus disease><coronavirus disease 2019><coronavirus disease 2019 infection><coronavirus disease 2019 virus><enroll><genetic approach><genetic determinant><genetic strategy><genetic variant><genomic variant><hCoV19><host response><immune system response><immunoresponse><infected with COVID-19><infected with COVID19><infected with SARS-CoV-2><infected with SARS-CoV2><infected with coronavirus disease 2019><infected with severe acute respiratory syndrome coronavirus 2><interest><intervention therapy><life-threatening COVID><life-threatening COVID-19><life-threatening SARS-CoV-2><life-threatening coronavirus disease><life-threatening coronavirus disease 2019><life-threatening severe acute respiratory syndrome coronavirus 2><molecular targeted therapeutics><molecular targeted therapies><molecular targeted treatment><nCoV2><pathway><predisposing gene><respiratory><serious COVID><serious COVID-19><serious SARS-CoV-2><serious coronavirus disease><serious coronavirus disease 2019><serious severe acute respiratory syndrome coronavirus 2><severe COVID><severe COVID-19><severe COVID19><severe SARS-CoV-2><severe coronavirus disease><severe coronavirus disease 19><severe coronavirus disease 2019><severe severe acute respiratory syndrome coronavirus 2><susceptibility allele><susceptibility locus><susceptibility variant><young adult><young adulthood><youngster>